subscribeSubscribe
The Biopharmaceutical Cartel And High Drug Prices

The Biopharmaceutical Cartel And High Drug Prices
John LaMattina FORBES
10 Apr 2019
Share Share
Medicare Part D no match for runaway specialty drug costs: study

Medicare Part D no match for runaway specialty drug costs: study
Mark Miller REUTERS
07 Feb 2019
Share Share
Merck runs out of Parkinson’s disease drug Sinemet as manufacturing issues

Merck runs out of Parkinson’s disease drug Sinemet as manufacturing issues
Eric Palmer FIERCE PHARMA
04 Oct 2018
Share Share
Merck Is Lowering Drug Prices. There’s a Catch

Merck Is Lowering Drug Prices. There’s a Catch
Jessie Hellman THE HILL
20 Jul 2018
Share Share
Merck write-downs $1.9bn as market shrinks

Merck write-downs $1.9bn as market shrinks
THE PENINSULAR QATAR
24 Feb 2017
Share Share
Merck takes US$1.9b writedown as hepatitis C market shrinks

Merck takes US$1.9b writedown as hepatitis C market shrinks
BUSINESS TIMES
23 Feb 2017
Share Share
Merck falls short in Q4 sales but sees EPS growth ahead

Merck falls short in Q4 sales but sees EPS growth ahead
Eric Sagonowsky FIERCE PHARMA
02 Feb 2017
Share Share
Two new hepatitis C therapies fast-tracked in Europe

Two new hepatitis C therapies fast-tracked in Europe
Phil Taylor PMLIVE
25 Jan 2017
Share Share
SMC OKs four new therapies for NHS use in Scotland

SMC OKs four new therapies for NHS use in Scotland
Selina McKee PHARMATIMES
18 Jan 2017
Share Share
AbbVie`s pan-genotypic hep C prospect shines in trials

AbbVie`s pan-genotypic hep C prospect shines in trials
Carly Helfand FIERCE PHARMA
14 Nov 2016
Share Share